Case report demonstrates adalimumab efficacy in Behçet's-like syndrome linked to a novel NF-κB1 mutation, highlighting targeted biologic options for complex autoinflammatory diseases.
Behçet's disease is a rare multisystem inflammatory disorder characterised by recurrent oral and genital ulceration with systemic involvement. Heterozygous mutations in NF-κB1 have been associated with Behçet's-like presentations. We present a woman with psoriasis, lichen sclerosus, non-small-cell lung cancer, anogenital ulcers and features of a Behçet's-like syndrome associated with a novel NF-κB1 mutation. She responded well to adalimumab after failed treatment with systemic and topical corticosteroids, antibiotics and colchicine.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: